Call to defend Belgium's top position in pharma industry in Europe

27 November 2023
brussels_large_credit_freeimages

The latest EU Pharma Figures clearly show Belgium has a leading position within the European Union in terms of biopharmaceutical research and development, production and export, says the sector’s trade group pharma.be in a website posting.

Although Belgium has only 2.6% of the EU population, the biopharma industry accounts for 7.8% of jobs, 18.7% of exports and 19.3% of R&D investments in the EU. This puts the sector in third, second and first place in Europe respectively.

Because of this top position, it is important that the country asserts itself at European level in important dossiers at hand, such as the revision of European pharmaceutical regulations and intellectual property rights. Especially when Belgium is President of the European Council in the first half of next year, the pharma.be stressed.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical